Vascular endothelial growth factor (VEGF) is reported to be implicated in the development of diabetic nephropathy. We performed a case-control study to determine if
VEGF-2578C→A,
VEGF-1499C→T, and
VEGF-635G→C single-nucleotide polymorphisms (SNPs) in the
VEGF gene are associated with predisposition to diabetic nephropathy in type 1 diabetes. Genomic DNA was obtained from Irish type 1 diabetic individuals with nephropathy (cases,
n=242) and those without nephropathy (controls,
n=301), in addition to 400 healthy control samples. These samples were genotyped for the three SNPs using TaqMan or Pyrosequencing technology. Chi-squared analyses revealed no significant differences in genotype or allele frequencies in cases versus controls for
VEGF-2578C→A (genotype,
P=.58; allele,
P=.52) and
VEGF-635G→C (genotype,
P=.58; allele,
P=.33). However, a positive association with diabetic nephropathy was observed for the
VEGF-1499T allele in the Northern Ireland population (
P <.001) and subsequently replicated in a separate population from the Republic of Ireland (
P <.001; combined,
P <.001). Carriage of the
VEGF-1499T allele was associated with a twofold excess risk of developing diabetic nephropathy (OR=2.24, 95 % CI=1.50–3.36,
P <.0001). No significant differences were found between the healthy control population and the type 1 diabetic population.
Our results suggest that the VEGF-1499T allele, or an allele in linkage disequilibrium with this allele, is associated with susceptibility to diabetic nephropathy in the Irish population.